Dr. de Andrade is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
- University of Alabama Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2000
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1994 - 1997
- Federal University of Rio Grande do Sul School of MedicineClass of 1990
Certifications & Licensure
- TN State Medical License 2019 - 2025
- AL State Medical License 1997 - 2024
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- AOA Alpha Omega Alpha Honor Medical Society, 2018
- Distinguished Chest Educator American College of Chest Physicians, 2017
- Jack D. Fulmer Award for Excellence in Teaching UAB, Division of Pulmonary, Allergy, and Critical Care Medicine, 2010, 2012
- Join now to see all
Clinical Trials
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF Start of enrollment: 2009 Oct 01
- AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis Start of enrollment: 2009 Oct 01
- Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- 38 citationsDisparities in lung transplantation before and after introduction of the lung allocation scoreKeith M. Wille, Kathy Harrington, Joao deAndrade, Sonia Vishin, Robert A. Oster
The Journal of Heart and Lung Transplantation. 2013-07-01 - 59 citationsPharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidenceLuca Richeldi, Francesco Varone, Miguel Bergna, Joao A. de Andrade, Jeremy A. Falk
European Respiratory Review. 2018-12-31 - 157 citationsPirfenidone safety and adverse event management in idiopathic pulmonary fibrosisLisa Lancaster, Joao A. de Andrade, Joseph D. Zibrak, Maria L. Padilla, Carlo Albera
European Respiratory Review. 2017-12-31
Journal Articles
- Oxidative Modifications of Protein Tyrosyl Residues are Increased in Plasma of Human Subjects with Interstitial Lung DiseasePennathur S, Vivekanandan-Giri A, Locy ML, Kulkarni T, Zhi D, Zeng L, Byun J, de Andrade J, Thannickal VJ, Am J Respir Crit Care Med, 1/17/2015
- Pleiotropic Effect of the Proton Pump Inhibitor Esomeprazole Leading to Suppression of Lung Inflammation and FibrosisGhebremarian YT, Cooke JP, Gerhart W, Griego C, Brower J, Doyle-Eisele M, Moeller BC, Zhou Q, Ho L, de Andrade J, Raghu G, Peterson L, Rivera A, Rosen GD, J Transl Med, 1/1/2015
- The Idiopathic Pulmonary Fibrosis Clinical Research Network: Diagnostic and Adjudication Processesde Andrade J, Schwarz M, Collard HR, Gentry-Bumpass T, Colby T, Lynch D, Kaner R; IPFnet Investigators, Chest, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Clinical Characteristics and Disease Burden of Newly Diagnosed IPF at Tertiary Care Centers: Initial Results from the Idiopathic Pulmonary Fibrosis-PROspective Outcome...Durheim M, O'Brien E, Gamerman V, Shrader P, Todd JL, Snyder L, Anstrom K, Belperio J, Culver D, de Andrade J, Roman J, Whelan TP, Palmer S, Conoscenti C, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
- A Bundle of Care Improves Outcomes in Idiopathic Pulmonary FibrosisKulkarni T, Acosta Lara P, Willoughby J, Kim Y, Ramachandran R, Alexander CB, Luckhardt T, Thannickal VJ, de Andrade J, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
- Next Generation Sequencing Does Not Support a Causative Role for Herpes Virus in IPFLasky J, Yin Q, Flemington E, Zhu D, Kaminski N, de Andrade J, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
- Join now to see all
Lectures
- Idiopathic Pulmonary Fibrosis1/1/2015
- Non-pharmacological management of Idiopathic Pulmonary FibrosisMontreal, QC, Canada - 1/1/2015
- Clinical Aspects of Other Interstitial Lung Diseases (Non-granulomatous)1/1/2011
- Join now to see all
Other Languages
- Portuguese, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: